Taymika capsules 0.53 g No. 30

composition

Myo-inositol 500.0 mg, L-methylfolate 208.0 mcg, vitamin D3 12.5 mcg (500 IU). Additional ingredients: lactose 13886 mg, calcium stearate 106 mg, aerosil 53 mg.

Energy value kcal/100 g: 10.0 kcal. Nutritional value per 100 g of product: Protein - 0 g, carbohydrates - 2.5 g, fats - 0 g.

Properties

Myo-inositol (vitamin B8) is one of the endogenous human metabolites that significantly affects the functioning of all tissues, including the reproductive system. Myo-inositol acts as an important signal transmitter in intracellular signaling cascades in the form of inositol phosphates and phosphatidylinositol lipids, participating in the regulation of intracellular calcium levels, insulin receptor signal transduction, fat breakdown and a decrease in receptor levels. Disturbance of myo-inositol metabolism leads to cell resistance to gonadotropin-releasing hormone, follicle-stimulating and luteinizing hormones, ovulation disorders, inhibition of egg maturation and insulin resistance. Myo-inositol is effective in the treatment of metabolic and reproductive disorders. The use of myo-inositol in preparation for in vitro fertilization (IVF) is also promising. Myo-inositol levels in the blood are an important biomarker of somatic and reproductive health. The use of myo-inositol (especially in combination with folate) is an effective way to correct reproductive and somatic disorders.

L-methylfolate is the most biologically active form of folic acid, capable of crossing the blood-brain barrier. It is the predominant trace element form of folate that circulates in blood plasma and participates in biological processes. It is necessary for the health of the cardiovascular and nervous systems, as well as for proper cell division. L-methylfolate increases peripheral insulin sensitivity, maintaining stable folate levels and thereby restoring normal homocysteine levels. Unlike folic acid, L-methylfolate has a higher bioavailability, has no medicinal or nutritional effects, is well absorbed and is stable.

Vitamin D3 plays a key role in calcium-phosphorus metabolism and affects bone mineral density. Vitamin D deficiency is associated with health risks, including cardiovascular disease, cancer, metabolic syndrome, multiple sclerosis, diabetes, and psychiatric disorders. A large percentage of people of reproductive age are deficient in vitamin D, which is an important component regulating calcium homeostasis and many other cellular functions.

Taimika helps prevent possible nutritional deficiencies of myo-inositol, folic acid and vitamin D3 and can be recommended by doctors to restore and maintain optimal dietary conditions for the functioning of the body, improve the metabolic profile, increase fertility, normalize the menstrual cycle and ovulation. planning and during pregnancy.

Recommendations for use

An additional source of myo-inositol, folic acid, and vitamin D3 when planning and during pregnancy contributes to the overall strengthening of the body, normalization of the functioning of the female reproductive system, and improvement of metabolism.

Method of application

Women take 1-2 capsules per day after meals, the course of treatment is from 3 to 6 months. The duration of the course and the possibility of a repeat course should be agreed with the doctor.

It is recommended to consult a doctor before use.

Reservation

For women during lactation, as prescribed and under the supervision of a doctor.

Contraindication

Individual sensitivity to components, children.

Packaging form.

Capsules 530 mg No. 30 in a package.

Expiration date

36 months.